Genetic Map Opens Door to Development of New Therapies to Reverse Bone Loss

An international team of scientists report that they have successfully mapped the cells and genes that regulate bone formation and loss and discovered the critical role that blood vessel cells play in bone health. By combining genomic sequencing with data from half a million individuals, the research team identified hundreds of previously unknown genes that govern bone health and revealed cells surrounding blood vessels as one of the drivers of bone repair.

Kensing on how “responsible beauty” will take over clean beauty

Clean beauty has historically been defined by an absence of chemical ingredients, restricting the sector to what a product isn’t, rather than what it is. That foundation is phasing into a new trajectory: communicating the total environmental impact across a product’s lifecycle. 

Gattefossé validates cosmetic ingredient production to strengthen US supply resilience

Gattefossé has validated five cosmetic ingredients at its manufacturing facility in Lufkin, Texas. The company says it is strengthening its manufacturing presence in North America, directly responding to its customers’ needs for more reliable supply chains and domestic sourcing options in what it calls an “unpredictable global market.” 

Kao targets Asia hair dyeing boom with repair ingredient after discovering days-long color damage

Kao Corporation’s Hair Beauty Research division has confirmed for “the first time” that structural protein damage inside hair can continue to progress for seven days after coloring. The effects are especially felt by people with melanin-rich hair, common across Asia.

From Field to Fuel: Vivescia, Roquette and Siplec E.Leclerc Join Forces to Build a Low-Carbon French Ethanol Value Chain

July 2026, Reims: VIVESCIA (a leading French grain cooperative group), Roquette (a global leader in plant…

Estée Lauder restructuring costs reach US$1.75B as job cuts deepen

Estée Lauder Companies (ELC) has announced that it expects to spend up to US$1.75 billion on its restructuring plan. The scheme was first announced in November 2023, when the company originally estimated it would cost between US$500 and 700 million. 

🎥 Inside Faraday Earth’s bid to make cheap green ammonia without Haber-Bosch

[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Faraday Earth] Can a container-sized plasma reactor…

会议报道丨十年论道,元年启航:第十届CPEW锚定中国创制农药全球化新起点

世界农化网中文网报道:2026年7月9日至10日,由AgroPages世界农化网、浙江省农药工业协会主办的"兰升生物·2026中国农药国际市场开拓交流会"(CPEW)在杭州举行。这是CPEW连续举办的第十个年头。两天时间里,来自20多个国家和地区的500余名代表齐聚一堂,30余位海内外演讲嘉宾轮番登台——从跨国巨头拜耳、巴斯夫的研发负责人,到中国创制企业的掌门人;从标普全球、Eurofins这样的国际数据与法规服务机构,到来自印度、巴西、巴拉圭、加拿大的一线从业者。没有哪一场行业论坛,能在两天之内把全球农化产业链的每一个关键节点——研发、专利、法规、供应链、渠道、资本——如此密集地摆上同一张桌面。

CriteriaCaixa targets €300M for biotech and tech by 2030

Why it matters: The commitment creates a potentially significant new source of capital for early-stage European biotechs, particularly in Spain and Portugal, although CriteriaCaixa has not specified how much of the €300m will go to life sciences.

🎥 Can non thermal plasma seed treatment move from lab curiosity to broadacre reality?

[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Sylvarum] Using non-thermal plasma or high voltage …